Cryoport Opens New Paris Facility for Temperature-Sensitive Biopharma Logistics
Cryoport, a leading provider of temperature-controlled logistics, has opened a new facility in Louvres, France. The site, located near Paris Charles de Gaulle Airport, is the third in Cryoport's Global Supply Chain Centre network. It offers cryogenic capabilities for temperature-sensitive materials, supporting various biopharma sectors including cell and gene therapies, biologics, animal health, and reproductive medicine.
The Louvres facility is part of Cryoport's strategic plan to support clinical and commercial advanced therapy programmes with integrated, end-to-end logistics services. The company aims to expand services at this location in the coming months to include biostorage, BioServices, QP drug management, Importer of Record (IOR) capabilities, and other offerings.
Jerrell Shelton, CEO of Cryoport, expressed that the new facility strengthens Cryoport Systems' Global Supply Chain Centre Network and enhances service to clients in European and global markets. The site is already supporting logistics for biopharma clients in various sectors, including cell and gene therapies, biologics, animal health, and reproductive medicine.
Cryoport's expansion in Louvres demonstrates its commitment to providing comprehensive, secure, and efficient logistics solutions for the biopharma industry. As the company continues to grow, it is expected to offer more services and support a wider range of clients in the future.
Read also:
- Trump and Xi speak over the phone, according to China's confirmation.
- Prices of transit tickets in Berlin and Brandenburg are on the rise
- Linde Wins Major Engineering Design Contract for Equinor's Low Carbon Hydrogen Project at H2H Saltend, Progressing Towards a Greener Future
- Economic Growth of Nitric Acid for Electronic Applications Anticipated to Reach 5.8% by 2034
